Core Insights - Fudan Zhangjiang (688505.SH) released its semi-annual report for 2025 on August 13, 2025, indicating significant institutional investment in the company [1] Institutional Holdings - As of August 12, 2025, four institutional investors disclosed holdings in Fudan Zhangjiang A-shares, totaling 306 million shares, which represents 29.52% of the company's total equity [1] - The institutional investors include New Venture Phase II Venture Capital, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Pudong New Area Emerging Industry Investment Co., Ltd., and Hong Kong Central Clearing Limited [1] - Compared to the previous quarter, the total institutional holding percentage increased by 0.28 percentage points [1] Public Fund and Foreign Investment - In the current period, one public fund was disclosed, which is the Wanji Pharmaceutical Quantitative Stock Selection Mixed Initiation A [1] - Regarding foreign investment, one new foreign institution was disclosed in the current period, namely Hong Kong Central Clearing Limited [1]
机构风向标 | 复旦张江(688505)2025年二季度已披露持仓机构仅4家